CIK 0001175680 · Non-accelerated filer<br>Smaller reporting company
CytoDyn Inc.
Sign in to watch- Ticker
- CYDY
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 753056237
- Phone
- 360-980-8524
- Business address
- 1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 98660
- Former names
- CYTODYN INC, REXRAY CORP
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- 10-K/A Report 10-K/A
- RW Other RW
- 4 Derivatives Options or other derivatives
- 4 Grant or award President acquired 646,552 shares (grant or award)
- UPLOAD Other SEC-generated Letter
- 4 Grant or award CMO acquired 9,457 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 8,965 shares (grant or award)
- 4 Grant or award CFO acquired 7,086 shares (grant or award)
- D/A Other Amended Notice of Exempt Offering of Securities
- S-3 Offering Registration Statement
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- EFFECT Other Notice of Effectiveness
- 4 Grant or award CFO acquired 8,313 shares (grant or award)
- 4 Grant or award CMO acquired 11,094 shares (grant or award)
Page 12 of 71 · 1,401 filings